Project Grant T32CA298969
Award Date 5/1/26
Completion Date 4/30/31
Dollars Obligated $163K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Los Angeles, CA 90032, USA
Similar Awards
- The University of California, Los Angeles (UCLA) received a $178,444 Project Grant award from the National Cancer Institute (NCI) under the Cancer Research Manpower program (CFDA 93.398), effective July 1, 2025, through June 30, 2030. This award funds the UCLA Surgeon-Scientist Basic Cancer Research Training Program (UCLA Surgeon-Scientist BCRTP), a comprehensive training initiative designed to develop the next generation of surgeon-scientists capable of conducting rigorous basic and...
- Federal Grant Award Summary The University of Southern California received a $681,676 Project Grant award from the National Cancer Institute under the Cancer Cause and Prevention Research program (CFDA 93.393), effective April 1, 2026 through March 31, 2031. This translational research initiative investigates per- and polyfluoroalkyl substances (PFAS) as novel risk factors for hepatocellular carcinoma (HCC) by integrating population-based epidemiological research with mechanistic laboratory...
- Federal Grant Award Summary The National Cancer Institute (NCI) awarded the University of Southern California a Project Grant totaling $650,450 under the Cancer Detection and Diagnosis Research program (CFDA 93.394), with performance extending from July 1, 2025 through June 30, 2030. This grant supports the development and translational advancement of IMT-423 (MHC-II-restricted CT83-specific CD4-dependent TCRM50A-STEM2 T cells), an innovative T cell receptor (TCR)-engineered CD4+ T cell...
- Federal Grant Award Summary The University of Southern California received a $712,735 Project Grant from the National Cancer Institute under the Cancer Treatment Research program (CFDA 93.395) effective June 1, 2025, with a completion date of April 30, 2030. This award supports a Phase II randomized clinical trial investigating the synergistic therapeutic potential of SEPHB4-HSA, an ephrinB2 inhibitor, combined with pembrolizumab (PD-1 antibody) in muscle invasive bladder cancer (MIBC) patients....
- Federal Grant Award Summary The University of Cincinnati received a $383,491 Project Grant from the National Cancer Institute (NCI) under the Cancer Research Manpower program (CFDA 93.398), effective July 1, 2025 through June 30, 2030. This award funds a Training Program in Basic and Translational Oncology designed to develop the next generation of cancer researchers capable of bridging laboratory discoveries with clinical applications. The program addresses a critical gap in the cancer research...
- Federal Project Grant Award Summary The Huntsman Cancer Institute (HCI) Oncological Data Science (ODSI) Training Program, funded by the National Cancer Institute under the Cancer Research Manpower program (CFDA 93.398), delivers a two-year predoctoral training program designed to develop early-career scientists as data ambassadors and innovators in cancer data science. The program supports six predoctoral candidates annually through comprehensive training that integrates biomolecular-anchored...
- Federal Project Grant Award Summary The National Cancer Institute (NCI) awarded $129,058 to the University of Southern California under the Cancer Research Manpower program (CFDA 93.398) on September 1, 2025, to support Dr. Anqi Wang's transition to an independent cancer and molecular epidemiology investigator through a Pathway to Independence Award (K99/R00). The award provides comprehensive research training and career development services, including investigation into the role of loss of Y...
- Federal Grant Award Summary The National Cancer Institute (NCI) awarded the Regents of the University of Minnesota a $309,761 Project Grant under the Cancer Research Manpower program (CFDA 93.398) effective May 1, 2026, through April 30, 2031. The award funds development and delivery of an innovative training course in biomarker development and applications for cancer prevention research. The course combines virtual didactic modules on chemical carcinogenesis fundamentals with a five-week...
- Federal Project Grant Summary The University of Michigan, Office of Research and Sponsored Projects, received a $319,505 Project Grant from the National Cancer Institute under the Cancer Research Manpower program (CFDA 93.398) awarded August 1, 2025, with completion by July 31, 2030. This five-year award supports the development of comprehensive nationwide training infrastructure in advanced methodological approaches for constructing and optimizing adaptive interventions across the cancer...
- The University of Southern California (USC) received a $704,882 Project Grant award from the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research program (CFDA 93.393) to define the genetic factors underlying familial prostate cancer in African American (AA) men. The project aims to develop improved risk prediction models that incorporate polygenic risk scores, pathogenic variants, and family history of prostate cancer for the AA population. By leveraging existing...